BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36243547)

  • 1. Mucosal and hormonal adaptations after Roux-en-Y gastric bypass.
    Feris F; McRae A; Kellogg TA; McKenzie T; Ghanem O; Acosta A
    Surg Obes Relat Dis; 2023 Jan; 19(1):37-49. PubMed ID: 36243547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
    Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.
    Jensen CZ; Bojsen-Møller KN; Svane MS; Holst LM; Hermansen K; Hartmann B; Wewer Albrechtsen NJ; Kuhre RE; Kristiansen VB; Rehfeld JF; Clausen TR; Holst JJ; Madsbad S
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G661-G672. PubMed ID: 32068442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass.
    Nergård BJ; Lindqvist A; Gislason HG; Groop L; Ekelund M; Wierup N; Hedenbro JL
    Surg Obes Relat Dis; 2015; 11(6):1237-46. PubMed ID: 26143297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.
    Rubino F; Gagner M; Gentileschi P; Kini S; Fukuyama S; Feng J; Diamond E
    Ann Surg; 2004 Aug; 240(2):236-42. PubMed ID: 15273546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
    Steinert RE; Feinle-Bisset C; Asarian L; Horowitz M; Beglinger C; Geary N
    Physiol Rev; 2017 Jan; 97(1):411-463. PubMed ID: 28003328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls.
    Martinussen C; Dirksen C; Bojsen-Møller KN; Svane MS; Carlsson ER; Hartmann B; Clausen TR; Veedfald S; Kristiansen VB; Rehfeld JF; Hansen HS; Holst JJ; Madsbad S
    Am J Clin Nutr; 2020 Jan; 111(1):28-41. PubMed ID: 31742316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
    Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
    Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
    Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.
    Roberts GP; Kay RG; Howard J; Hardwick RH; Reimann F; Gribble FM
    Surg Obes Relat Dis; 2018 May; 14(5):562-568. PubMed ID: 29548882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass.
    de Hollanda A; Jiménez A; Corcelles R; Lacy AM; Patrascioiu I; Vidal J
    Surg Obes Relat Dis; 2014; 10(5):814-9. PubMed ID: 24969090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
    Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
    Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.